Effect of SGLT-2 Inhibitors in Patients With T2DM and Moderate to Severe Liver Fibrosis

Condition:   Type2diabetes Intervention:   Sponsors:   Diabetes Foundation, India;   National Diabetes Obesity and Cholesterol Foundation Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials